What are the management of dka

Reading File
Finding Sources
Finding Sources
Searching PubMed

"diabetic ketoacidosis" AND management

Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have excellent, detailed information from multiple authoritative textbooks. Let me compile a comprehensive answer.

Management of Diabetic Ketoacidosis (DKA)

DKA is a medical emergency defined by the triad of hyperglycemia (glucose >250 mg/dL), ketonemia/ketonuria (2+ or >3.0 mmol/L), and metabolic acidosis (pH <7.3, bicarbonate <18 mmol/L).

Severity Classification

SeveritypHHCO₃Mental Status
Mild7.25–7.3015–18Alert
Moderate7.00–7.2410–14Drowsy
Severe<7.00<10Stupor/Coma

The 5 Pillars of DKA Management

1. Fluid Resuscitation

Fluid losses are typically 5–10 liters in adults (water deficit ~70-100 mL/kg).
  • If in hypovolemic shock: Give isotonic crystalloid (0.9% NS) as fast as possible in adults; 20 mL/kg bolus in children, repeated until systolic BP ≥80 mmHg
  • Moderate dehydration (no shock): 1–2 L of 0.9% NS over the first 1–2 hours, then 15–20 mL/kg/h
  • After initial resuscitation: Switch to 0.45% NS (hypotonic saline) at a slower rate
  • When glucose falls to ≤250–300 mg/dL: Add dextrose 5% (D5W) to IV fluids (while continuing insulin) to prevent hypoglycemia and allow ongoing insulin to clear ketones
Note: Large volumes of 0.9% NS can worsen hyperchloremic metabolic acidosis. Balanced crystalloids (Plasmalyte) show promise for faster normalization of physiologic parameters. - Rosen's Emergency Medicine, p. 2544

2. Insulin Therapy

Critical rule: Do NOT start insulin if K⁺ < 3.3 mEq/L - correct potassium first.
  • Mild–Moderate DKA: Can be treated with subcutaneous rapid-acting insulin analogs (recent evidence supports this as an alternative to IV infusion)
  • Severe DKA: Requires IV regular insulin
Standard IV Protocol:
  • Option A: 0.1 unit/kg/h continuous infusion (no bolus)
  • Option B: 0.1 unit/kg IV bolus, then 0.1 unit/kg/h infusion
  • If glucose does not fall by ≥10% in the first hour: give a rescue bolus of 0.1 unit/kg
Glucose targets during treatment:
  • Target glucose fall: 50–70 mg/dL/hr
  • When glucose reaches 250 mg/dL: Add D5W to fluids, reduce insulin to 0.05–0.1 unit/kg/h to maintain glucose 150–250 mg/dL
  • Continue insulin until ketoacidosis resolves (pH >7.3, HCO₃ >15, anion gap normalized)
Transition to subcutaneous insulin:
  • Give first dose of SC insulin 1–2 hours before stopping IV infusion to prevent rebound ketosis
Barash's Clinical Anesthesia, p. 4059; Rosen's Emergency Medicine, p. 2544

3. Potassium Replacement

Despite often-normal or high initial serum K⁺ (due to acidosis pushing K⁺ extracellularly), total body potassium is always depleted (deficit 3–7 mEq/kg). Once insulin starts and acidosis corrects, K⁺ shifts intracellularly and levels can plummet dangerously.
Serum K⁺Action
< 3.3 mEq/LHold insulin; give IV K⁺ first; replace to >3.3 mEq/L before starting insulin
3.3–5.5 mEq/LGive insulin + add 20–40 mEq KCl per liter of IV fluid; maintain K⁺ 4–5 mEq/L
> 5.5 mEq/LGive insulin; hold K⁺; monitor every 2 hours
Continuous ECG monitoring is recommended when K⁺ replacement rate exceeds 10 mEq/h. - Barash's Clinical Anesthesia, p. 4059

4. Other Electrolytes

Phosphate:
  • Levels fall during treatment (insulin drives phosphate intracellularly)
  • Routine replacement is generally not necessary unless severe hypophosphatemia develops (can cause skeletal muscle weakness, impaired ventilation, hemolytic anemia)
  • Replace if serum phosphate < 1.0 mg/dL
Magnesium:
  • Correct with 1–2 g MgSO₄ IV if deficient; serum levels may not reflect body stores
Sodium:
  • Corrected with 0.9% NS or 0.45% NS depending on phase of resuscitation
  • Measured Na⁺ is often falsely low due to osmotic shift from hyperglycemia (correct: add 1.6–2.4 mEq/L Na⁺ per 100 mg/dL glucose above 100 mg/dL)

5. Bicarbonate Therapy

Generally NOT recommended - multiple studies show no benefit in resolution of acidosis or time to discharge.
Only consider if:
  • pH < 7.1 with hemodynamic instability, OR
  • pH < 6.9 even without hemodynamic instability
Give 50–100 mEq NaHCO₃ IV if indicated, with close monitoring.

Identify and Treat the Precipitant

Always search for the underlying cause (the most common precipitants are listed in Goldman-Cecil Medicine):
  • Most common: Infections, insulin non-adherence, new-onset T1DM, acute coronary syndrome
  • Others: Stroke, pulmonary embolism, pancreatitis, medications (corticosteroids, SGLT2 inhibitors, atypical antipsychotics, cocaine)

Special Situations

SGLT2 Inhibitor-Associated (Euglycemic) DKA

  • Blood glucose may be normal or only mildly elevated - can be missed
  • SGLT2 inhibitor effect persists 10–14 days after discontinuation
  • Treat the same way; maintain dextrose in IV fluids; avoid stopping insulin prematurely

Airway/Intubation

  • Avoid intubation if possible - the patient's tremendous respiratory drive (Kussmaul breathing) is compensatory; matching it on a ventilator is challenging
  • If intubation is necessary (comatose, vomiting), maintain hyperventilation post-intubation to prevent acidosis worsening

Monitoring (Meticulous Flow Sheet)

ParameterFrequency
GlucoseEvery 1 hour
K⁺, Na⁺, Cl⁻, HCO₃⁻, pHEvery 2–4 hours
Fluid in/urine outHourly
Vital signsContinuous
ECGContinuous (if high-dose K⁺ replacement)

Resolution Criteria (DKA "Cleared")

  • Blood glucose < 200 mg/dL
  • Serum bicarbonate ≥ 15 mEq/L
  • Venous pH > 7.3
  • Anion gap normalized (≤12 mEq/L)

Recent Evidence Update

Recent meta-analyses (2024–2026) are refining protocols:
  • A 2024 meta-analysis (PMID 39090718) found subcutaneous insulin to be a safe and effective alternative to continuous IV infusion in adult DKA - shorter hospital stays with comparable outcomes
  • A 2026 meta-analysis (PMID 41208563) on early subcutaneous basal insulin co-administered with IV insulin found it reduced time to transition and shortened hospital stay without increasing hypoglycemia

Sources: Rosen's Emergency Medicine, p. 2542-2545; Goldman-Cecil Medicine, p. 2484; Barash's Clinical Anesthesia, p. 4059; ADA Potassium/Phosphorus Repletion Guidelines
This is a shared conversation. Sign in to Orris to start your own chat.